Skip to main content

Neuroactivation and Vasoactivation Studies in Patients with Impaired Cognitive Function Using Tc-99m-HMPAO-SPECT

  • Chapter
  • 124 Accesses

Part of the book series: Advances in Pharmacological Sciences ((APS))

Summary

Early stages of dementia of Alzheimer type (DAT) often fail to show characteristic patterns of local cerebral blood flow (lCBF). The present study deals with the question whether characteristic lCBF deficits can be produced or enhanced by activation. 22 patients underwent vasomotor activation by 500 mg acetazolamide and 33 patients cognitive activation by labyrinth task prior to 500 MBq Tc-HMPAO administration. According to visual scoring vasomotor activation decreased the fraction of patients with abnormal patterns from 16/22 (73 %) to 7/22 (32 %.) In contrast, neuroactivation increased the number of definitely abnormal patient studies from 19 (58 %) to 27 (82 %) out of 33 studies.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984; 34: 939–944.

    Article  PubMed  CAS  Google Scholar 

  2. Hachinski VC, IliffLD, Zilkha E, DuBoulay GH, McAllister VL, Marshall J, Russel WR, Symon L. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632–637.

    Google Scholar 

  3. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adez M, Leirer V. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiat Res 1983; 17: 37–49.

    Article  CAS  Google Scholar 

  4. Ostwald WD, Fleischmann VM. Der Labyrinthtest. In: Nürnberger Altersinventar Manual (NM), Hogrefe Verlag, Göttingen-Bern-Toronto 1995; 64–82.

    Google Scholar 

  5. Scheibel AB, Duong T, Tomiyasu U. Denervation microangiopathy in senile dementia. Alzheimer type. Alzheimer Dis Assoc Disord 1987; 11: 19–37.

    Article  Google Scholar 

  6. Stoppe G, Schütze R, Kögler A, Staedt J, Munz D, Emrich D, Rüther E. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimers type: relationship to disease severity. Dementia 1995; 6: 73–82.

    PubMed  CAS  Google Scholar 

  7. Bonte FJ, Devous MD, Reisch JS, Ajmani AK, Weiner MF, Hom J, Tintner R. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer’s disease or stroke as measured by single-photon emission computed tomography. Invest Radiol 1989; 24: 99103.

    Article  Google Scholar 

  8. Kuwabara Y, Ichiya Y, Otsuka M, Masuda K, Ichimiya H, Fujishima M. Cerebrovascular responsiveness to hypercapnia in Alzheimer’s dementia and vascular dementia of the Binswanger type. Stroke 1992; 23: 594–598.

    Article  PubMed  CAS  Google Scholar 

  9. Miller JD, DeLeon MJ, Ferris SH, Kluger A, George AE, Reisberg B, Sachs HJ, Wolf HP. Abnormal temporal lobe response in Alzheimer’s disease during cognitive processing as measured by C-11–2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab 1987; 7: 248251.

    Google Scholar 

  10. Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlette E, Teng E, Cotman CW. Temporal hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer’s type and controls. Preliminary studies. Arch Gen Psychiatry 1991; 48: 840–847.

    Article  PubMed  CAS  Google Scholar 

  11. Kessler J, Herholz K, Grond M, Heiss WD. Impaired metabolic activation in Alzheimer’s disease. A PET study during continuous visual recognition. Neuropsychologia 1991; 29 /3: 229–243.

    Article  PubMed  CAS  Google Scholar 

  12. Frackowiak RSJ, Pozzilli C. Legg NJ. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981; 104: 753–778.

    Article  PubMed  CAS  Google Scholar 

  13. Friedland RP, Budinger TF, Ganz E. Regional cerebral metabolic alterations in dementia of the Alzheimers type: Positron emission tomgography with F-18 fluorodeoxyglucose. J Comput Assist Tomogr 1986; 7: 590–598.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Basel AG

About this chapter

Cite this chapter

Dannenberg, C., Marschall, B., Zedlick, D., Bettin, S., Seese, A., Knapp, W.H. (1997). Neuroactivation and Vasoactivation Studies in Patients with Impaired Cognitive Function Using Tc-99m-HMPAO-SPECT. In: Bergmann, H., Kroiss, A., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7772-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7772-5_15

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-7774-9

  • Online ISBN: 978-3-0348-7772-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics